Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Gene Therapy Releasable-linkage-and-compositions-containing-same

 Hepatitis C virus inhibitors
OF THE INVENTION Stereochemical definitions and conventions used herein generally follow McGraw-H...


 Expression of recombinant glyoprotein B from herpes simplex virus
The nucleotide sequence and the amino acid sequence derived therefrom are provided for Herpes S...


 Enhancing agent for nerve growth factor production comprising a compound having a coumarin backbone or a compound having a 2-dimethyl chroman backbone
The invention claimed is: 1. A therapeutic agent or prophylactic agent for a disease requiring ...


 In vitro packaging of adeno-associated virus DNA
It is an object of the present invention to provide a method for packaging a DNA substrate in an in ...


 Recombinant viral vector system
The present invention relates to the in vitro synthesis of a novel 165 basepair fragment of DNA ...


 Modified adeno-associated virus vector capable of expression from a novel promoter
This invention provides an adeno-associated viral vector comprising the inverted terminal repeat ...


 Culturable mitochondrial cells with no nucleus, showing mitochondrial activity
OF THE INVENTION Hereinafter, the present invention will be described in detail. (1) Method of P...


 Antisense oligonucleotides inhibiting human bcl-2 gene expression
The invention provides oligodeoxynucleotides and methods for inhibiting growth of lymphoma or ...


 Process for the synthesis of oligomeric compounds
What is claimed is: 1. A method for the preparation of an oligomeric compound having a moiety of F...


 Process for oligonucleotide synthesis
OF THE PREFERRED EMBODIMENTS The present invention is directed to methods for linking a ...


 Releasable linkage and compositions containing same

Details
Inventors: Zalipsky, Samuel;
Assignee: Alza Corporation (Mountain View, CA)
Primary Examiner: Riley; Jezia
Assistant Examiner:
Attorney, Agent or Firm: Mohr; Judy M., Mahoney; Jacqueline F., Simboli; Paul B.

A compound comprised of a hydrophilic polymer covalently yet reversibly linked to a amine-containing ligand through a dithiobenzyl linkage is described.

DETAILED DESCRIPTION Accordingly, it is an object of the invention to provide a compound where a ligand is covalently yet reversibly linked to a hydrophilic polymer.
Upon cleavage of the linkage, the ligand in its native form is regenerated.
In one aspect, the invention includes a compound having the general structure: ##STR1## wherein R.
sup.
1 is a hydrophilic polymer comprising a linkage for attachment to the dithiobenzyl moiety; R.
sup.
2 is selected from the group consisting of H, alkyl and aryl; R.
sup.
3 is selected from the group consisting of O(C.
dbd.
O)R.
sup.
4, S(C.
dbd.
O)R.
sup.
4, and O(C.
dbd.
S)R.
sup.
4 ; R.
sup.
4 comprises an amine-containing ligand; and R.
sup.
5 is selected from the group consisting of H, alkyl and aryl; and where orientation of CH.
sub.
2 --R.
sup.
3 is selected from the ortho position and the para position.
In one embodiment, R.
sup.
5 is H and R.
sup.
2 is selected from the group consisting of CH.
sub.
3, C.
sub.
2 H.
sub.
5 and C.
sub.
3 H.
sub.
8.
In another embodiment, R.
sup.
2 and R.
sup.
5 are alkyls.
In another embodiment, the amine-containing ligand R.
sup.
4 is selected from the group consisting of a polypeptide, an armine-containing drug and an amine-containing lipid.
In an embodiment where the amine-containing ligand R.
sup.
4 is an amine-containing lipid, the lipid includes either a single hydrocarbon tail or a double hydrocarbon tail.
In one preferred embodiment, the lipid is a phospholipid having a double hydrocarbon tail.
The hydrophilic polymer R.
sup.
1 can be, in yet another embodiment, selected from the group consisting of polyvinylpyrrolidone, polyvinylmethylether, polymethyloxazoline, polyethyloxazoline, polyhydroxypropyloxazoline, polyhydroxypropyl-methacrylamide, polymethacrylamide, polydimethyl-acrylamide, polyhydroxypropylmethacrylate, polyhydroxyethylacrylate, hydroxymethylcellulose, hydroxyethylcellulose, polyethyleneglycol, polyaspartamide, copolymers thereof, and polyethyleneoxide-polypropylene oxide.
In one preferred embodiment, the hydrophilic polymer R.
sup.
1 is polyethyleneglycol



Related patents
  Solid phase dispersion of quinolone or naphthyridonecarboxylic acids
What is claimed is: 1. A solid phase dispersion comprising a micronized quinolinecarboxylic acid or micronized naphthyridonecarboxylic acid in an insoluble matrix, ...
  Peptide, process for its preparation and pharmaceutical composition containing same
We claim: 1. pGlu-Pro-Pro-Gly-Gly-Ser-Lys-Val-Ile-Leu-Phe. 2. A pharmaceutical composition for cell-growth stimulating action comprising an effective amount of the ...
  Stable pharmaceutical composition and method for its production
It is an object of the present invention to provide a stable pharmaceutical composition wherein the absorbability of a lipophilic drug which is insoluble or practically ...
  Pharmaceutical composition for treatment of adult respiratory distress syndrome containing human ANP
The present invention has been accomplished under these circumstances and has as an object providing a pharmaceutical composition effective against ARDS, more ...
  Peptide, a method for its preparation and a pharmaceutical composition containing the peptide
OF THE PREFERRED EMBODIMENT The following standard abbreviations for the amino acid residues are used throughout the specification: Ala--alanine; Glu--glutamic acid; P...
  Mimotopes and anti-mimotopes of human platelet glycoprotein Ib/IX
The invention provides an isolated peptide that functionally mimics a binding site for a monoclonal antibody, the monoclonal antibody recognizing an epitope within the ...
  Adjuvant and vaccine compositions containing monophosphoryl lipid A
What is claimed: 1. A lyophilized composition comprising 0.2% up to 5% by weight 3-O-desacyl-4'-monophosphoryl lipid A, at least 70% by weight of sugar and 0% to about 30...
  Methods for preparation of vaccines against cancer
The present invention relates to methods for producing increased amounts of immunogenic material which can be used for prevention and treatment of cancer. The ...
  Human genes and gene expression products V
OF THE INVENTION The invention relates to polynucleotides comprising the disclosed nucleotide sequences, to full length cDNA, mRNA genomic sequences, and genes ...
  Haptotactic peprides
The invention claimed is: 1. An isolated haptotactic peptide of 20 amino acids consisting of the amino acid sequence as set forth in SEQ ID NO:1, characterized in that ...

0.004

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved